Baystreet.ca - Horizon Takes it on Chin as Sale to Amgen Blocked

Horizon Therapeutics’ (NASDAQ:HZNP) stock price plunged soon after Tuesday’s open after a report that the Federal Trade Commission is preparing to file a lawsuit to block the biotech company’s $27.8 billion sale to Amgen.

The FTC could sue to block ...

Related Keywords

Ireland , ,Amgen ,Bloomberg ,Horizon Therapeutic ,Federal Trade Commission ,California Based Amgen ,Horizon Therapeutics ,